Scientific Programme Committee
We are delighted to confirm the Scientific Programme Committee for the 17th Migraine Trust International Symposium
Shazia AfridiConsultant Neurologist
Guy’s and St Thomas’ NHS Trust
Dr Afridi qualified from Guy’s and St Thomas’ Medical School with an intercalated neuroscience degree. Following her basic medical training in London she completed her PhD at the Institute of Neurology, Queen Square looking at functional imaging in migraine. She then went on to complete her higher training in London and is a Consultant Neurologist at Guy’s and St Thomas’ NHS Trust where she runs the headache service in the neurology department. She has been a council member for BASH, British Association for the Study of Headache and is a trustee for the Migraine Trust.
Fayyaz AhmedConsultant Neurologist and Hon. Senior Lecturer
Hull and Yorkshire Hospitals NHS Trust and Hull York Medical School
Dr Fayyaz Ahmed is a Consultant Neurologist and Hon. Senior Lecturer at Hull and Yorkshire Hospitals NHS Trust and Hull York Medical School. Dr Ahmed graduated from Dow Medical College Karachi, Pakistan in 1986. He moved on to the UK after his residency and received his neurology training at St James’s University Hospital, Leeds and Imperial College London. He did his research on cerebral blood flow in migraine and clinical training in headache at the Princess Margaret Migraine Clinic, Charing Cross Hospital, London. He was appointed as Consultant Neurologist in Hull in 1996 where he established a dedicated headache clinic. He did his MBA in Public Sector Management from University of Hull in 2010 and is currently the Educational Officer of the British Association for the Study of Headache having served as a Secretary (2005-2008), Vice Chair (2009-2010) and Chair (2011-2013). He is a member of the headache advisory group for the Association of British Neurologist; former Chair of Headache UK, Director of the European Headache and Migraine Trust International Congress (EHMTIC) and Trustee of the International Headache Society. He is a keen educationalist involved in headache education across the globe.
Messoud AshinaProfessor of Neurology
Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
Messoud Ashina is Professor of Neurology in the Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. He is also Director of the Human Migraine Research Unit at the Danish Headache Center and Department of Neurology, Rigshospitalet Glostrup.
Professor Ashina has been actively involved in headache research since 1995. His research interests include experimental migraine and cluster headache models, functional neuroimaging, novel antimigraine drug targets, mechanism of migraine and action of anti-migraine medications. He has authored over 300 papers, abstracts and book chapters on the topic of headache, including migraine.
Andrew CharlesProfessor of Neurology
UCLA School of Medicine
Andrew Charles is Director of the UCLA Goldberg Migraine Program, which includes basic and clinical research, education, and care of patients with headache disorders. His laboratory focuses on cellular and pharmacological mechanisms of migraine and pain, with a particular interest in the development of novel therapies. He is an associate editor of the journal Cephalalgia, and he has served on the Board of Trustees of the International Headache Society. He currently holds the position of Secretary of the American Headache Society.
David DodickProfessor of Neurology
Mayo Clinic College of Medicine
David W Dodick, MD, FRCP (C), FACP, is Professor of Neurology at the Mayo Clinic College of Medicine. He is the Founder and Program Director of the Mayo Clinic Neurology Residency Program and Headache Medicine Fellowship Program. He is the Founder and Medical Director of the Mayo Clinic Headache Program as well as the Comprehensive Concussion Center at Mayo Clinic in Phoenix, Arizona. Dr Dodick is board certified by the Royal College of Physicians and Surgeons of Canada and the American Board of Psychiatry and Neurology. He also holds United Council for Neurologic Subspecialties certification in headache medicine and American Board of Psychiatry and Neurology certification in vascular neurology.
Dr Dodick has authored and/or co-authored more than 270 peer-reviewed publications and co-authored 7 books. He serves as Editor in Chief of Cephalalgia and is on the editorial board of several journals including The Neurologist and Lancet Neurology. He is the immediate Past-President of the American Headache Society (AHS). He is the Chair of the American Migraine Foundation and Chair of the Academic Headache Program Director's Consortium. He is also the Vice-Chair of the World Federation of Neurology Headache Research Group.
He is a member of the scientific committee of the Migraine Trust and a Subcommittee Chair for the ICHD-2 and ICHD-3 classification committee. He served as Chair of the Scientific Committee for the International Headache Congress in Philadelphia PA, in 2009. He was a principle author of the International Headache Society Clinical Trials Guidelines for the Prevention of Chronic Migraine
Lars Edvinsson is a Professor at Lund University in Internal Medicine, MD DMSci, and Chairman of the Swedish Migraine Society. In addition he is a Board member of the European Headache Federation.
In 2008 Lars Edvinsson was called to be professor at the Copenhagen University in "Receptor Regulation in Cerebrovascular and Cardiovascular Diseases" and in 2007 was Founder, and is now Director, of the Glostrup Research Park, Copenhagen. In 2012 he received a Lifetime Achievement award from American Headache colleagues (Stowe, VT), and an Honoray Dr Hon Causa in Szeged, Hungary.
Philip HollandSenior Lecturer
King’s College London
Dr Philip R Holland. Senior Lecturer, King’s College London.
Migraine is the 7th most disabling disorder in the world and as such sufferers face a severe unmet need for a greater understanding and treatments to lighten their burden. My passion is to act on both these fronts using my scientific background developed initially during my BSc Neuroscience at the University of Glasgow and subsequently focusing on primary headache disorders during my PhD at University College London, United Kingdom. I gained further research experience as a post-doctoral researcher at the University of California San Francisco, United Sates, and finally at the University of Edinburgh, United Kingdom.
I am currently a senior lecturer at the Institute of Psychiatry, Psychology and Neuroscience, King’s College London, United Kingdom where I lead a preclinical research team with the fundamental goal of developing an improved understanding of the basic biology of migraine and other primary headaches. Our projects are currently funded by the Medical Research Council, Migraine Trust and the Wellcome Trust. We further acknowledge previous funding from the European Research Council and our ongoing collaborations with Industrial partners.
When not undertaking research and teaching I am a committee member of the British Association for the Study of Headache (BASH), on the scientific committee of the Migraine Trust International Symposium (MTIS), an associate editor for Cephalalgia, a science editor for the CGRP forum and strive to increase the public awareness of primary headaches.
Rigmor JensenAssociate Professor and Lecturer
The University of Copenhagen
Medical Degree from University of Copenhagen 1981. Neurological residency at University Hospitals in Copenhagen. Fellowship at The Headache Clinic in Gentofte Hospital, University of Copenhagen under supervision of Professor Jes Olesen, and received a medical doctoral degree from University of Copenhagen in 1999.
Rigmor has been associated professor and lecturer at The University of Copenhagen since 1997 and was appointed as professor in Headache and Neurological Pain in 2007. Has conducted or been involved in numerous epidemiological, clinical, and neurophysiological studies of migraine, tension-type and cluster headache since 1988. Rigmor has published more than 250 scientific papers in refereed journals and more than 50 text books chapters and had been the supervisor of 3 doctoral theses and 12 PhD theses.
Co-founder of the Danish Headache Center, a multidisciplinary academic headache center, at Rigshospitalet-Glostrup, which was awarded as Global Excellence in Health in 2010 and 2014.
Has been working extensively with national and international organisation of headache care, pre- and postgraduate education in headache since 1988, is past president of EHF, and now board member and co-chair of IHS educational committee.
NHS Devon Headache Clinic
David Kernick is a GP with a special interest and runs the NHS Devon headache clinic. He chairs the primary care group of the British Association for the Study of Headache and was previously headache champion for the Royal College of General Practitioners.
Richard LiptonProfessor and Vice-Chair of Neurology
Richard B. Lipton, M.D., is the Edwin S Lowe Professor and Vice-Chair of Neurology, Professor of Epidemiology and Population Health and Professor of Psychiatry and Behavioral Sciences at Einstein. He also is Director of the Montefiore Headache Center. After graduating from the University of Chicago Pritzker School of Medicine, he did both a neurology residency and a fellowship in Clinical Neurophysiology and Epilepsy at Einstein. He did a second fellowship in Neuro-epidemiology at the Columbia University. A UCNS-certified headache clinician, he is also a clinical trialist and epidemiologist. He is Past President of the American Headache Society. He is also Chair of the AHS’s Chronic Migraine Education Program (CMEP).
He has written over 750 articles in peer reviewed journals and 10 books, including two editions of Wolff’s Headache, as well as Headache in Clinical Practice and Migraine and Other Headaches. His research interests include the epidemiology and burden of episodic migraine as well as risk factors and prevention of chronic migraine. He has developed several measures widely used in clinical practice and research, including ID-Migraine, ID-Chronic Migraine, the Migraine Disability Assessment Scale (MIDAS), the Migraine Treatment Optimization Questionnaire (mTOQ), as well as the Allodynia Symptom Checklist (ASC). His work has also examined migraine genetics and biomarkers, migraine’s comorbidities as well as health-related quality of life and health economics. He has conducted numerous clinical trials and lead national and international clinical trials. He is on the Editorial Boards of several journals including Neurology. He is a four time winner of the Wolff Award and recipient of the Enrico Greppi Award, all for excellence in headache research.
Arne MayProfessor of Neurology
Department of Systems Neuroscience at the University of Hamburg
Arne May is a Professor of Neurology in the Department of Systems Neuroscience at the University of Hamburg and head of the headache outpatient clinic of the University clinic of Hamburg. His major research interests are the basic mechanisms of headpain, the chronification of pain and plasticity within the human brain. The work of his group involves human imaging studies in primary headache as well as experimental studies of trigeminovascular nociception, with the aim of understanding how to modulate headache syndromes and chronicity of pain. Prior to his position at the University of Hamburg, Professor May was a clinician and conducted research into pain and headache syndromes at the University of Regensburg. Prior to this he completed his residency in the Neurology Department of the University of Essen, followed by post-doctorate studies at the Institute of Neurology in London. Professor May is currently a member of the Board of trustees of the International Headache Society since 2013. He has published over 280 original and review articles and is since 2016 the Editor of Cephalalgia.
Koen PaemeleireTreasurer of the European Headache Federation
Koen Paemeleire obtained his Medical Degree in 1995 at the University of Ghent, Belgium. He earned a PhD in Medical Sciences based on calcium signalling research with Professor Luc Leybaert at the Department of Physiology and Pathophysiology in Ghent and as a Fulbright Scholar with Professor Michael J. Sanderson at the Department of Physiology of the UMASS Medical Center, MA, USA. He completed a five-year residency training programme in Neurology chaired by Professor Jacques De Reuck in Ghent.
He trained in headache medicine with Professor Peter J. Goadsby at the National Hospital for Neurology and Neurosurgery, Queen Square, London, UK. He works as a consultant neurologist at the Department of Neurology, Ghent University Hospital, Belgium since 2004, where he runs a specialized headache clinic. He was also appointed part-time Senior Lecturer in Neurophysiology at the Department of Basic Medical Sciences, Faculty of Medicine and Health Sciences, Ghent University, Belgium.
He is currently Treasurer of the European Headache Federation and Associate Editor of the Journal of Headache and Pain. His research focuses on the management of headache, neurostimulation techniques and migraine neurobiology. He is involved in multiple clinical trials testing CGRP (receptor) antibodies in the prevention of migraine and cluster headache.
Allan PurdyProfessor of Medicine (Neurology)
Allan Purdy MD, FRCPC, is Professor of Medicine (Neurology) at Dalhousie University. He was Professor and Head of the Department of Medicine, and Chief of the Medicine Service of the Department of Medicine at Dalhousie and Capital Health from 2005 to June of 2011. He is a Fellow of the Royal College of Physicians of Canada, and was elected a Fellow of the American College of Physicians in 2008. He previously was the Professor and Head of Neurology at Dalhousie from 1994 to 2006. He is a Fellow of the American Headache Society in and is the President of the American Headache Society.
Dr. Purdy is Past - President of the Canadian Headache Society. He is the Chair of the Education Committee of the International Headache Society and is on the Board of Directors of the both societies. He directs headache educational courses worldwide, and has received Excellence in Teaching Awards on many occasions. He has been involved in guideline develop for the treatment of migraine and is involved in clinical research in migraine and has several publications.
He is co-editor of Advanced Therapy of Headache and co-author of Headache Pocket Clinician 2010 from Cambridge University Press. In 2005 he received the Arnold P. Friedman Distinguished Clinician Research Award from the American Headache Society for outstanding contribution to the field of headache, and the 2007 Life Time Achievement Award from the Headache Cooperative of New England. He has been on the Editorial Board of Cephalalgia and is currently an Associate Editor for Headache.
He is a Fellow of the American Headache Society and is the current President of the American Headache Society. By September he will be the Immediate Past President of the American Headache Society.
Stephen SilbersteinProfessor of Neurology
Stephen D. Silberstein, MD
Professor of Neurology
Director, Jefferson Headache Center
Thomas Jefferson University
Stephen D. Silberstein, MD, is a Professor of Neurology and the Director of the Jefferson Headache Center at Thomas Jefferson University. He is a Fellow of the American College of Physicians, the American Academy of Neurology, the American Neurologic Association and the American Headache Society. He has served the American Headache Society as President, Treasurer, and member of the Board of Directors. In 2016, he was awarded a Lifetime Achievement Award by the American Headache Society. Dr Silberstein is an active member of the American Academy of Neurology. He was Co-director of the national and international Headache Guideline Project, in cooperation with the Agency for Health Care Policy and Research. He was the Chairman of the International Headache Society meeting in Philadelphia in 2009. He was Chairman of the headache research group of the World Federation of Neurology.
Dr. Silberstein received his medical degree from the University of Pennsylvania. He did his internship and Junior Medical residency at the hospital of the University of Pennsylvania After completing a fellowship in neurology at the National Hospital for Nervous Diseases in London, Dr. Silberstein served as a Pharmacology Research Associate in the Toxicology Laboratory of Clinical Science at the National Institutes of Mental Health, and completed a neurology residency at the Hospital of the University of Pennsylvania.
Dr. Silberstein is the Senior Editor of the 8th edition of Wolff's Headache and Other Head Pain. He was associate Editor of Cephalalgia and CNS Drugs, and a present or prior member of the Editorial Board of Headache; Cephalalgia; Acta Neurologica Scandinavica; Journal of Neurology, Neurosurgery & Psychiatry; and Topics in Pain Management. He is an ad hoc reviewer for many publications, including The New England Journal of Medicine; Brain, The Lancet, JAMA, Mayo Clinic Proceedings, Annals of Neurology, and Neurology.
Dr. Silberstein has more than 300 publications to his credit. He lectures extensively on the pathogenesis, neurobiology, diagnosis, and treatment of headache.
Cristina TassorelliProfessor of Neurology
Department of Brain and Behavioural Sciences of the University
Cristina Tassorelli, MD, PhD, fully trained neurologist, is Full Professor of Neurology at the Dept of Brain and Behavioural Sciences of the University of Pavia and a senior consultant in neurology at the C. Mondino National Neurological Institute of Pavia (Italy), where she directs the Headache Science Centre. She is also a senior consultant in the Neurorehabilitation and Parkinsons’ Disease Units of the C. Mondino National Neurological Institute.
Cristina Tassorelli received a medical degree summa cum laude from the University of Pavia. She completed an internship and her training as a neurologist at the University of Pavia, in collaboration with the C. Mondino National Neurological Institute, and obtained a PhD Degree in Human Psychobiology at the University of Modena (Italy).
Dr. Tassorelli has authored more than 200 peer-reviewed publications and she has co-authored 6 books.
She has served as director in the Board of the International Headache Society, as co-chair of the Scientific Committee for IHC2017 and she is presently coordinating the IHS Committee for Clinical Trials. In 2005, she has participated in the foundation of the European Headache Alliance, where she has served as Vice-President for several years. She is Specialty Chief Editor of Frontiers in Neurology for the section ‘Headache Medicine and Facial Pain’, and member of the editorial board of several scientific journals.
Mark WeatherallConsultant Neurologist
Charing Cross and Ealing Hospitals
Dr Mark Weatherall read medical sciences at Cambridge, then pursued a career as a medical historian for six years, before going back to complete his clinical training. He trained in neurology at Oxford, Nottingham, Preston and Manchester, before an interest in headache brought him to the National Hospital for Neurology and Neurosurgery, where he was a clinical fellow in the Headache Group run by Peter Goadsby and Holger Kaube.
Since 2017 he has been a consultant neurologist at Charing Cross and Ealing Hospitals. In 2018 he takes up a post as consultant neurologist to Buckinghamshire Healthcare NHS Trust.
He has clinical and research interests in the history of headache, the factors that drive chronic migraine, and in visual snow. He has served as a Trustee of the Migraine Trust, and on the council of the British Association for the Study of Headache.
Peter GoadsbyProfessor of Neurology
King’s College London
Peter Goadsby obtained his basic medical degree and training at the University of New South Wales, Australia. Neurology training was done with Prof James W. Lance and clinical neurophysiology with Prof David Burke in Sydney. After post‐doctoral work in New York with Don Reis at Cornell, with Jacques Seylaz at Universite VII, Paris, and post‐graduate neurology training at Queen Square, London with Professors C David Marsden, Andrew Lees, Anita Harding and W Ian McDonald, he returned to the University of New South Wales, and the Prince of Wales Hospital, Sydney as a consultant neurologist and was promoted to Associate Professor of Neurology. He was appointed a Wellcome Senior Research Fellow at the Institute of Neurology, University College London in 1995. He was Professor of Clinical Neurology and Honorary Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London until 2007.
He has been Professor of Neurology, Department of Neurology, University of California, San Francisco since 2007. He has been an Honorary Consultant Neurologist at the Hospital for Sick Children, Great Ormond St, London since 1998.
In 2013 he was appointed Director, NIHR‐Wellcome Trust King’s Clinical Research Facility, King’s College Hospital, Professor of Neurology at King’s College London and Honorary Consultant Neurologist, King’s College Hospital.
His major research interests are in the basic mechanisms of primary headache disorders, such as migraine and cluster headache, in both experimental and clinical settings, and translating these insights into their better management.